Bayesian Capital Management, LP Trans Medics Group, Inc. Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $145,240 - $301,240	2,000 New	2,000 $301,000
Q4 2023 Feb 14, 2024	BUY	$36.74 - $81.08 $312,290 - $689,180	8,500 Added 41.6%	28,935 $2.28 Million
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $705,804 - $1.27 Million	13,200 Added 182.45%	20,435 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$66.23 - $88.73 $185,444 - $248,444	-2,800 Reduced 27.9%	7,235 $607,000
Q1 2023 May 15, 2023	BUY	$53.63 - $82.33 $48,267 - $74,097	900 Added 9.85%	10,035 $759,000
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $356,995 - $587,289	9,135 New	9,135 $563,000

395

31.1M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.09B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.